Synergistic Effects of Novel Naphthoquinone Derivatives Against Clinical Methicilin-Resistant Staphylococcus aureus Strain - Archive ouverte HAL
Poster De Conférence Année : 2022

Synergistic Effects of Novel Naphthoquinone Derivatives Against Clinical Methicilin-Resistant Staphylococcus aureus Strain

Résumé

The emergence of multidrug resistant (MDR) bacteria requires interest in the medical field and thereby an urgent need to develop efficient and specific methods in targeting unique bacterial cellular processes. Menadione (Vitamin K3) showed interesting properties as membrane integrity, two-component system and efflux pump disruptor. Novel series of 1,4-naphthoquinone based on menadione have been designed and synthesized starting from juglone and naphthazarin, following a Minisci-type reaction.
Fichier principal
Vignette du fichier
Poster_RECOB_VD.pdf (366.1 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03700525 , version 1 (21-06-2022)

Identifiants

  • HAL Id : hal-03700525 , version 1

Citer

Valentin Duvauchelle, Chaimae Majdi, David Bénimélis, Catherine Dunyach-Rémy, Patrick Meffre, et al.. Synergistic Effects of Novel Naphthoquinone Derivatives Against Clinical Methicilin-Resistant Staphylococcus aureus Strain. REncontres en Chimie Organique Biologique 18 (RECOB18), Mar 2022, Aussois, France. . ⟨hal-03700525⟩

Collections

UNIMES
60 Consultations
58 Téléchargements

Partager

More